Surrogate endpoints and non-inferiority trials in chronic viral hepatitis

Journal of Hepatology

Volumn 52, Issue 5, 2010, Pages 778-

  Gentile, Ivan ^a   Borgia, Guglielmo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; NUCLEOSIDE ANALOG; NUCLEOTIDE DERIVATIVE; TENOFOVIR;

CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL; VIROLOGY; VIRUS MUTATION; VIRUS RESISTANCE;

ANTIVIRAL AGENTS; CLINICAL TRIALS AS TOPIC; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 77951648047     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.12.023     Document Type: Letter

References (7)

1. Garattini S., and Bertelè V. Ethics in clinical research. J Hepatol 51 (2009) 792-797
2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 50 (2009) 227-242
3. Bruno S., Stroffolini T., Colombo M., Bollani S., Benvegnù L., Mazzella G., et al. Italian Association of the Study of the Liver Disease (AISF). Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology 45 (2007) 579-587
4. Veldt B.J., Saracco G., Boyer N., Cammà C., Bellobuono A., Hopf U., et al. Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. Gut 53 (2004) 1504-1508
5. George S.L., Bacon B.R., Brunt E.M., Mihindukulasuriya K.L., Hoffmann J., and Di Bisceglie A.M. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology 49 (2009) 729-738
6. Braks R.E., Ganne-Carrie N., Fontaine H., Paries J., Grando-Lemaire V., Beaugrand M., et al. Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin. World J Gastroenterol 13 (2007) 5648-5653
7. Dienstag J.L., Goldin R.D., Heathcote E.J., Hann H.W., Woessner M., Stephenson S.L., et al. Histological outcome during long-term lamivudine therapy. Gastroenterology 124 (2003) 105-117